SOAT1 and cancer: Small molecule inhibitors of JAK/STAT signaling have been shown to repress cell proliferation by affecting cell viability in a variety of solid tumor cell lines, as well as in blood malignant cell lines, suggesting the critical role of JAK/STAT signaling in the proliferation of cancer cells [32-35].